Red Tortoise LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.37K Hold
138
﹤0.01% 315
2025
Q4
$7.44K Hold
138
﹤0.01% 330
2025
Q3
$6.22K Hold
138
﹤0.01% 346
2025
Q2
$6.39K Hold
138
﹤0.01% 329
2025
Q1
$8.42K Hold
138
﹤0.01% 270
2024
Q4
$7.8K Hold
138
﹤0.01% 292
2024
Q3
$7.14K Sell
138
-400
-74% -$18.8K ﹤0.01% 309
2024
Q2
$22.3K Buy
538
+364
+209% +$16.3K 0.01% 148
2024
Q1
$9.44K Buy
+174
New +$8.86K 0.01% 235
2023
Q4
Sell
-348
Closed -$20.2K 537
2023
Q3
$20.2K Buy
+348
New +$21.3K 0.01% 130
2023
Q2
Sell
-116
Closed -$8.04K 559
2023
Q1
$8.04K Sell
116
-66
-36% -$4.66K 0.01% 201
2022
Q4
$13.1K Buy
+182
New +$13.7K 0.01% 204
2021
Q4
Sell
-163
Closed -$12K 123
2021
Q3
$12K Buy
+163
New +$10.7K 0.01% 202

Other funds holding BMY

Red Tortoise LLC's BMY Position: Q1 2026 in Review

Red Tortoise LLC held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 138 shares worth $8.37K. The position accounts for ﹤0.01% of the portfolio, ranked #315.

Red Tortoise LLC first reported a position in BMY in Q3 2021 and has held it in 13 quarters since. The position peaked at $22.3K in Q2 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Red Tortoise LLC held 138 shares of Bristol-Myers Squibb worth $8.37K as of Q1 2026.
  • Red Tortoise LLC left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #315 holding.
  • Red Tortoise LLC first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 13 quarters since.
  • Red Tortoise LLC's Bristol-Myers Squibb position peaked at $22.3K in Q2 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.